Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
General Probiotics is a biotechnology company focused on developing innovative cell-based antimicrobials to eliminate pathogens in the food supply chain and improve animal health. The company utilizes advanced synthetic biology and precision engineering to create "smart" probiotics that can detect and neutralize specific harmful bacteria like Salmonella and Campylobacter. By providing an alternative to traditional antibiotics, General Probiotics aims to combat antimicrobial resistance while enhancing the safety and sustainability of global food production. Their technology is designed for seamless integration into existing agricultural practices, offering a scalable solution for livestock and poultry producers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on General Probiotics.